Power over pain: A brief review of current and novel interventions for endometriosis-associated pain

Journal of Endometriosis and Pelvic Pain Disorders

Volumn 6, Issue 4, 2014, Pages 163-173

  Ray, Kristeena L ^a   Mitchell, Brenda L ^a   Santanam, Nalini ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; Nociception; Oxidative stress; Therapeutics

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; ANTINOCICEPTIVE AGENT; ANTIOXIDANT; AROMATASE INHIBITOR; ASCORBIC ACID; CHEMOKINE RECEPTOR CX3CR1; DANAZOL; DIENOGEST; ELAGOLIX; FRACTALKINE; GESTAGEN; GONADORELIN DERIVATIVE; MELATONIN; MU OPIATE RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; PYCNOGENOL; RESVERATROL; SODIUM CHANNEL BLOCKING AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTORELIN; VANILLOID RECEPTOR 1;

CLINICAL TRIAL (TOPIC); DRUG EFFICACY; ENDOMETRIOSIS; HORMONAL THERAPY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NOCICEPTIVE PAIN; OXIDATIVE STRESS; PAIN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 84920870985     PISSN: 22840265     EISSN: 22840273     Source Type: Journal    
DOI: 10.5301/je.5000199     Document Type: Review

References (109)

1. Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012;98(3):511-519.
2. Ciarmela P, Critchley H, Christman GM, Reis FM. Pathogenesis of endometriosis and uterine fibroids. Obstet Gynecol Int. 2013;2013:656571:1-2.
3. Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261-275.
4. Young VJ, Brown JK, Saunders PT, Horne AW. The role of the peritoneum in the pathogenesis of endometriosis. Hum Reprod Update. 2013;19(5):558-569.
5. Platteeuw L, D’Hooghe T. Novel agents for the medical treatment of endometriosis. Curr Opin Obstet Gynecol. 2014;26(4): 243-252.
6. Bulletti C, Coccia ME, Battistoni S, Borini A. Endometriosis and infertility. J Assist Reprod Genet. 2010;27(8):441-447.
7. Fraser IS. Mysteries of endometriosis pain: Chien-Tien Hsu Memorial Lecture 2009. J Obstet Gynaecol Res. 2010;36(1): 1-10.
8. Revised American Fertility Society classification of endometriosis: 1985. Fertil Steril. 1985;43(3):351-352.
9. American Society for Reproductive. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997;67(5):817-821.
10. Roberts CP, Rock JA. The current staging system for endometriosis: does it help? Obstet Gynecol Clin North Am. 2003; 30(1):115-132.
11. Kobayashi H, Yamada Y, Morioka S, Niiro E, Shigemitsu A, Ito F. Mechanism of pain generation for endometriosis-associated pelvic pain. Arch Gynecol Obstet. 2014;289(1):13-21.
12. Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril. 2014;101(4):927-935.
13. Stratton P, Berkley KJ. Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications. Hum Reprod Update. 2011;17(3):327-346.
14. Morotti M, Vincent K, Brawn J, Zondervan KT, Becker CM. Peripheral changes in endometriosis-associated pain. Hum Reprod Update. 2014;20(5):717-736.
15. Brown J, Farquhar C. Endometriosis: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2014;3: CD009590.
16. Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H. Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol. 2002;83 (1-5): 149-155.
17. Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447): 1789-1799.
18. Arici A, Tazuke SI, Attar E, Kliman HJ, Olive DL. Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Mol Hum Reprod. 1996;2(1):40-45.
19. Ferrero S, Remorgida V, Maganza C, et al. Aromatase and endometriosis: estrogens play a role. Ann N Y Acad Sci. 2014; 1317(1):17-23.
20. Maia H Jr., Haddad C, Casoy J. Combining oral contraceptives with a natural nuclear factor-kappa B inhibitor for the treatment of endometriosis-related pain. Int J Womens Health. 2013;6:35-39.
21. Practice Committee of American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis. Fertil Steril. 2008;90(5)(Suppl):S260-S269.
22. Vercellini P, Fedele L, Pietropaolo G, Frontino G, Somigliana E, Crosignani PG. Progestogens for endometriosis: forward to the past. Hum Reprod Update. 2003;9(4):387-396.
23. Schweppe K. The current place of progestins in the treatment of endometriosis. Expert Review of Obstetrics & Gynecology. 2012;7(2):141-148.
24. Singh AK, Chattopadhyay R, Chakravarty B, Chaudhury K. Altered circulating levels of matrix metalloproteinases 2 and 9 and their inhibitors and effect of progesterone supplementation in women with endometriosis undergoing in vitro fertilization. Fertil Steril. 2013;100(1):127-134.
25. Mönckedieck V, Sannecke C, Husen B, et al. Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model. Mol Hum Reprod. 2009;15(10):633-643.
26. Huang HF, Hong LH, Tan Y, Sheng JZ. Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis. Fertil Steril. 2004;81(5):1235-1239.
27. Osteen KG, Bruner-Tran KL, Keller NR, Eisenberg E. Progesterone- mediated endometrial maturation limits matrix metalloproteinase (MMP) expression in an inflammatory-like environment: a regulatory system altered in endometriosis. Ann N Y Acad Sci. 2002;955:37-47 [discussion: 86-88, 396-406].
28. Mahnke JL, Dawood MY, Huang JC. Vascular endothelial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis. Fertil Steril. 2000;73(1):166-170.
29. Petraglia F, Hornung D, Seitz C, et al. Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Arch Gynecol Obstet. 2012;285(1):167-173.
30. Strowitzki T, Marr J, Gerlinger C, Faustmann T, Seitz C. Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis. Int J Gynaecol Obstet. 2012;117(3):228-233.
31. Leone Roberti Maggiore U, Scala C, Remorgida V, et al. Triptorelin for the treatment of endometriosis. Expert Opin Pharmacother. 2014;15(8):1153-1179.
32. Gargiulo AR, Hornstein MD. The role of GnRH agonists plus add-back therapy in the treatment of endometriosis. Semin Reprod Endocrinol. 1997;15(3):273-284.
33. Practice bulletin no. 114: management of endometriosis. Obstet Gynecol. 2010;116(1):223-236.
34. Zupi E, Marconi D, Sbracia M, et al. Add-back therapy in the treatment of endometriosis-associated pain. Fertil Steril. 2004;82(5):1303-1308.
35. Diamond MP, Carr B, Dmowski WP, et al. Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study. Reprod Sci. 2014;21(3):363-371.
36. Carr B, Dmowski WP, O’Brien C, et al. Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density. Reprod Sci. 2014;21(11):1341-1351.
37. Struthers RS, Nicholls AJ, Grundy J, et al. Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix. J Clin Endocrinol Metab. 2009; 94(2):545-551.
38. Selak V, Farquhar C, Prentice A, Singla A. Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst Rev. 2007;(4):CD000068.
39. Barbieri RL. Danazol: molecular, endocrine, and clinical pharmacology. Prog Clin Biol Res. 1990;323:241-252.
40. Pavone ME, Bulun SE. Aromatase inhibitors for the treatment of endometriosis. Fertil Steril. 2012;98(6):1370-1379.
41. Amsterdam LL, Gentry W, Jobanputra S, Wolf M, Rubin SD, Bulun SE. Anastrazole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril. 2005;84(2):300-304.
42. Ailawadi RK, Jobanputra S, Kataria M, Gurates B, Bulun SE. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil Steril. 2004;81(2):290-296.
43. Cobellis L, Razzi S, De Simone S, et al. The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis. Eur J Obstet Gynecol Reprod Biol. 2004;116(1):100-102.
44. Wu MH, Lu CW, Chuang PC, Tsai SJ. Prostaglandin E2: the master of endometriosis? Exp Biol Med (Maywood). 2010;235(6):668-677.
45. Badawy SZ, Marshall L, Cuenca V. Peritoneal fluid prostaglandins in various stages of the menstrual cycle: role in infertile patients with endometriosis. Int J Fertil. 1985;30(2): 48-52.
46. Nasir L, Bope ET. Management of pelvic pain from dysmenorrhea or endometriosis. J Am Board Fam Pract. 2004; 17(Suppl):S43-S47.
47. Barcena de Arellano ML, Mechsner S. The peritoneum: an important factor for pathogenesis and pain generation in endometriosis. J Mol Med (Berl). 2014;92(6):595-602.
48. Duffy JM, Arambage K, Correa FJ, et al. Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev. 2014;4:CD011031.
49. Healey M, Cheng C, Kaur H. To excise or ablate endometriosis? A prospective randomized double blinded trial after 5 years follow-up. J Minim Invasive Gynecol. 2014.
50. Giudice LC. Clinical practice. Endometriosis. N Engl J Med. 2010;362(25):2389-2398.
51. Shah PR, Adlakha A. Laparoscopic management of moderate: severe endometriosis. Journal of Minimal Access Surgery. 2014;10(1):27-33.
52. Acien P, Velasco I. Endometriosis: a disease that remains enigmatic. ISRN Obstet Gynecol. 2013;2013:242149:1-2.
53. Rogers PA, D’Hooghe T., Fazleabas A, et al. Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci. 2009;16(4):335-346.
54. Murphy AA, Santanam N, Parthasarathy S. Endometriosis: a disease of oxidative stress? Semin Reprod Endocrinol. 1998;16(4):263-273.
55. Santanam N, Kavtaradze N, Murphy A, Dominguez C, Parthasarathy S. Antioxidant supplementation reduces endometriosis- related pelvic pain in humans. Transl Res. 2013; 161(3):189-195.
56. Santanam N, Murphy AA, Parthasarathy S. Macrophages, oxidation, and endometriosis. Ann N Y Acad Sci. 2002;955: 183-198.
57. Koca I, Tutoglu A, Boyaci A, et al. An evaluation of oxidative stress and antioxidant capacity in patients with myofascial pain syndrome. Mod Rheumatol. 2014;24(6): 992-996.
58. Fatima G, Das SK, Mahdi AA. Oxidative stress and antioxidative parameters and metal ion content in patients with fibromyalgia syndrome: implications in the pathogenesis of the disease. Clin Exp Rheumatol. 2013;31(6)(Suppl 79): S128-S133.
59. Lousse JC, Van Langendonckt A, Defrere S, Ramos RG, Colette S, Donnez J. Peritoneal endometriosis is an inflammatory disease. Front Biosci (Elite Ed). 2012;4(1):23-40.
60. Carvalho LF, Samadder AN, Agarwal A, Fernandes LF, Abrão MS. Oxidative stress biomarkers in patients with endometriosis: systematic review. Arch Gynecol Obstet. 2012;286(4): 1033-1040.
61. Murphy AA, Santanam N, Morales AJ, Parthasarathy S. Lysophosphatidyl choline, a chemotactic factor for monocytes/Tlymphocytes is elevated in endometriosis. J Clin Endocrinol Metab. 1998;83(6):2110-2113.
62. Proudfoot JM, Beilin LJ, Croft KD. PGF2-isoprostanes formed during copper-induced oxidation of low-density lipoproteins are the prostaglandins that cross-react with PGE2 antibodies. Biochem Biophys Res Commun. 1995;206(2):455-461.
63. Patwardhan AM, Akopian AN, Ruparel NB, et al. Heat generates oxidized linoleic acid metabolites that activate TRPV1 and produce pain in rodents. J Clin Invest. 2010;120(5):1617-1626.
64. Patwardhan AM, Scotland PE, Akopian AN, Hargreaves KM. Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia. Proc Natl Acad Sci USA. 2009;106(44):18820-18824.
65. Polak G, Barczynski B, Kwasniewski W, et al. Low-density lipoproteins oxidation and endometriosis. Mediators Inflamm. 2013;2013:624540:1-4.
66. Rong R, Ramachandran S, Santanam N, Murphy AA, Parthasarathy S. Induction of monocyte chemotactic protein-1 in peritoneal mesothelial and endometrial cells by oxidized low-density lipoprotein and peritoneal fluid from women with endometriosis. Fertil Steril. 2002;78(4):843-848.
67. Zeller JM, Henig I, Radwanska E, Dmowski WP. Enhancement of human monocyte and peritoneal macrophage chemiluminescence activities in women with endometriosis. Am J Reprod Immunol Microbiol. 1987;13(3):78-82.
68. Ngô C, Chéreau C, Nicco C, Weill B, Chapron C, Batteux F. Reactive oxygen species controls endometriosis progression. Am J Pathol. 2009;175(1):225-234.
69. Sharma I, Dhaliwal LK, Saha SC, Sangwan S, Dhawan V. Role of 8-iso-prostaglandin F2alpha and 25-hydroxycholesterol in the pathophysiology of endometriosis. Fertil Steril. 2010;94(1):63-70.
70. Seeber BE, Czech T, Buchner H, et al. The vitamin E-binding protein afamin is altered significantly in the peritoneal fluid of women with endometriosis. Fertil Steril. 2010;94(7):2923-2926.
71. Turgut A, Özler A, Görük NY, Tunc SY, Evliyaoglu O, Gül T. Copper, ceruloplasmin and oxidative stress in patients with advanced-stage endometriosis. Eur Rev Med Pharmacol Sci. 2013;17(11):1472-1478.
72. Ponce C, Torres M, Galleguillos C, et al. Nuclear factor kappaB pathway and interleukin-6 are affected in eutopic endometrium of women with endometriosis. Reproduction. 2009;137(4):727-737.
73. Brenner RM, Nayak NR, Slayden OD, Critchley HO, Kelly RW. Premenstrual and menstrual changes in the macaque and human endometrium: relevance to endometriosis. Ann N Y Acad Sci. 2002;955:60-74 [discussion: 86-88, 396-406].
74. Garmendia JV, De Sanctis JB. Perspectives of new therapies for endometriosis. Recent Pat Endocr Metab Immune Drug Discov. 2012;6(3):218-223.
75. Alvarez P, Levine JD. Screening the role of pronociceptive molecules in a rodent model of endometriosis pain. J Pain. 2014;15(7):726-733.
76. Agic A, Xu H, Finas D, Banz C, Diedrich K, Hornung D. Is endometriosis associated with systemic subclinical inflammation? Gynecol Obstet Invest. 2006;62(3):139-147.
77. Bedaiwy MA, Falcone T. Peritoneal fluid environment in endometriosis: clinicopathological implications. Minerva Ginecol. 2003;55(4):333-345.
78. Capobianco A, Rovere-Querini P. Endometriosis, a disease of the macrophage. Front Immunol. 2013;4:9.
79. Kim JG, Keshava C, Murphy AA, Pitas RE, Parthasarathy S. Fresh mouse peritoneal macrophages have low scavenger receptor activity. J Lipid Res. 1997;38(11):2207-2215.
80. Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9(8):807-819.
81. Simsek Y, Gul M, Yilmaz E, Ozerol IH, Ozerol E, Parlakpinar H. Atorvastatin exerts anti-nociceptive activity and decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-αin a rat endometriosis model. Arch Gynecol Obstet. 2014;290(5):999-1006.
82. Wang Y, Fu Y, Xue S, et al. The M2 polarization of macrophage induced by fractalkine in the endometriotic milieu enhances invasiveness of endometrial stromal cells. Int J Clin Exp Pathol. 2014;7(1):194-203.
83. Wang Y, Chen H, Fu Y, et al. MiR-195 inhibits proliferation and growth and induces apoptosis of endometrial stromal cells by targeting FKN. Int J Clin Exp Pathol. 2013;6(12): 2824-2834.
84. Shimoya K, Zhang Q, Temma-Asano K, Hayashi S, Kimura T, Murata Y. Fractalkine in the peritoneal fluid of women with endometriosis. Int J Gynaecol Obstet. 2005;91(1):36-41.
85. Bellelis P, Barbeiro DF, Rizzo LV, Baracat EC, Abrão MS, Podgaec S. Transcriptional changes in the expression of chemokines related to natural killer and T-regulatory cells in patients with deep infiltrative endometriosis. Fertil Steril. 2013;99(7): 1987-1993.
86. Guo Y, Chen Y, Liu LB, et al. IL-22 in the endometriotic milieu promotes the proliferation of endometrial stromal cells via stimulating the secretion of CCL2 and IL-8. Int J Clin Exp Pathol. 2013;6(10):2011-20.
87. Fedele L, Berlanda N. Emerging drugs for endometriosis. Expert Opin Emerg Drugs. 2004;9(1):167-177.
88. Schwager K, Bootz F, Imesch P, Kaspar M, Trachsel E, Neri D. The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model. Hum Reprod. 2011;26(9):2344-2352.
89. Kyama CM, Mihalyi A, Simsa P, et al. Role of cytokines in the endometrial-peritoneal cross-talk and development of endometriosis. Front Biosci (Elite Ed). 2009;1:444-454. Elite Ed Medline.
90. Neziri AY, Bersinger NA, Andersen OK, Arendt-Nielsen L, Mueller MD, Curatolo M. Correlation between altered central pain processing and concentration of peritoneal fluid inflammatory cytokines in endometriosis patients with chronic pelvic pain. Reg Anesth Pain Med. 2014;39(3): 181-184.
91. Rocha MG, e Silva JC, Ribeiro da Silva A, Candido Dos Reis FJ, Nogueira AA, Poli-Neto OB. TRPV1 expression on peritoneal endometriosis foci is associated with chronic pelvic pain. Reprod Sci. 2011;18(6):511-515.
92. Song N, Leng JH, Lang JH. [Expression of transient receptor potentials of vanilloid subtype 1 and pain in endometriosis] [article in Chinese]. Zhonghua Fu Chan Ke Za Zhi. 2012;47(5): 333-336.
93. Greaves E, Grieve K, Horne AW, Saunders PT. Elevated peritoneal expression and estrogen regulation of nociceptive ion channels in endometriosis. J Clin Endocrinol Metab. 2014;99(9):E1738-E1743.
94. Basbaum AI, Fields HL. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci. 1984;7(1):309-338.
95. Millan MJ. Descending control of pain. Prog Neurobiol. 2002;66(6):355-474.
96. Matsuzaki S, Canis M, Pouly JL, Botchorishvili R, Déchelotte PJ, Mage G. Differential expression of genes in eutopic and ectopic endometrium from patients with ovarian endometriosis. Fertil Steril. 2006;86(3):548-553.
97. Matsuzaki S, Canis M, Pouly JL, Botchorishvili R, Déchelotte PJ, Mage G. Both GnRH agonist and continuous oral progestin treatments reduce the expression of the tyrosine kinase receptor B and mu-opioid receptor in deep infiltrating endometriosis. Hum Reprod. 2007;22(1): 124-128.
98. Schwertner A, Conceição Dos Santos CC, Costa GD, et al. Efficacy of melatonin in the treatment of endometriosis: a phase II, randomized, double-blind, placebo-controlled trial. Pain. 2013;154(6):874-881.
99. Porpora MG, Brunelli R, Costa G, et al. A promise in the treatment of endometriosis: an observational cohort study on ovarian endometrioma reduction by N-acetylcysteine. Evid Based Complement Alternat Med. 2013;2013:240702: 1-7.
100. Flower A, Lewith GT, Little P. A feasibility study exploring the role of Chinese herbal medicine in the treatmentof endometriosis. J Altern Complement Med. 2011;17(8): 691-699.
101. Jiang H, Shen Y, Wang XG. Current progress of Chinese medicinal treatment of endometriosis. Chin J Integr Med. 2010;16(3):283-288.
102. Allen C, Hopewell S, Prentice A, Gregory D. Nonsteroidal anti- inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev. 2009;(2):CD004753.
103. Takai E, Taniguchi F, Nakamura K, Uegaki T, Iwabe T, Harada T. Parthenolide reduces cell proliferation and prostaglandin E2 [corrected] in human endometriotic stromal cells and inhibits development of endometriosis in the murine model. Fertil Steril. 2013;100(4):1170-1178.
104. Kohama T, Herai K, Inoue M. Effect of French maritime pine bark extract on endometriosis as compared with leuprorelin acetate. J Reprod Med. 2007;52(8):703-708.
105. Kohama T, Suzuki N, Ohno S, Inoue M. Analgesic efficacy of French maritime pine bark extract in dysmenorrhea: an open clinical trial. J Reprod Med. 2004;49(10):828-832.
106. Maia H Jr, Haddad C, Pinheiro N, Casoy J. Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain. Int J Womens Health. 2012;4:543-549.
107. Kalso E. Sodium channel blockers in neuropathic pain. Curr Pharm Des. 2005;11(23):3005-3011.
108. Wickström K, Bruse C, Sjösten A, Spira J, Edelstam G. Quality of life in patients with endometriosis and the effect of pertubation with lidocaine: a randomized controlled trial. Acta Obstet Gynecol Scand. 2013;92(12):1375-1382.
109. Hearn L, Derry S, Phillips T, Moore RA, Wiffen PJ. Imipramine for neuropathic pain in adults. Cochrane Database Syst Rev. 2014;5:CD010769.